MedPath

The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease

Completed
Conditions
Covid19
Chronic Kidney Diseases
Proteinuria
Registration Number
NCT04874753
Lead Sponsor
Uşak University
Brief Summary

COVID-19 pandemic affected the admission of patients to the hospital especially the older patients (\> 65 years old) because of curfews and the reluctance of patients to apply to the hospitals. Chronic kidney disease is characterized with the progressive loss of kidney function over the time and regular follow-up of patients for their kidney function and treatment of complications is recommended in these patients.

Detailed Description

The chronis kidney disease patients followed in Nephrology outpatient unit are going to be enrolled in the study and their kidney functions (calculated with the mdrd formula to asses the estimated glomerular filtration rate (eGFR)) will be evaluated 6 months before and after the COVID-19 pandemia. And the rate of initiation of renal replacement therapies and the change in proteinuria will be evaluated 6 months before and after the COVID-19 pandemic.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • patients with chronic kidney disease on regular follow-up for 6 months before the COVID19 pandemic.
Exclusion Criteria
  • patients without chronic kidney disease
  • patients not on routine follow-up for 6 months before the COVID19 pandemic

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eGFR change6 months

a rise or decrease in eGFR

change in proteinuria6 months

increase or decrease in ptoteinuria levels

Secondary Outcome Measures
NameTimeMethod
initiation of renal replacement therapies6 months

need for hemodialysis or peritoneal dialysis

Trial Locations

Locations (1)

Usak University

🇹🇷

Usak, Turkey

© Copyright 2025. All Rights Reserved by MedPath